• Clinical and preclinical regulations you need to be aware of, as demystified as possible. 
• How the computer thinks about image analysis, and how the most common biomarker algorithms work. 
• Is the computer lying? Practical ways to evaluate algorithm performance. 
• Putting pathologists back in charge - taming the patho-droid paranoia 

Hosted by Steve Potts, CEO of Flagship Biosciences: 

Dr. Potts joined Flagship from Aperio, where he was Vice President of Life Sciences. He managed worldwide sales and marketing in the biopharma segment, where his team achieved global adoption by nearly all of the largest pharmaceutical companies. He defined and led the GLP product development and validation services for the use of whole slide images in regulated preclinical and clinical trials studies, as well as the development of image analysis techniques for angiogenesis. Prior to Aperio, he was Head of Bioinformatics and Biostatistics at Quest Diagnostics Nichols Institute, where his team supported the development of In Vitro Diagnostics Multianalyte Assays (IVDMIA) in oncology and other therapeutic areas. He was a product manager at Accelrys, where he created a protein-ligand data management system for medicinal and computational chemists, crystallographers, and biologists to provide structural bioinformatics data across multiple pharmaceutical departments. He earned a Ph.D. and M.S. in Biological Engineering, and an MBA from the University of California at Davis, and a B.S. in Physics from Wheaton College, Illinois. He has over 20 peer-reviewed publications and patents.